EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

F2,6BP restores mitochondrial genome integrity in Huntington’s disease

Anirban Chakraborty, Santi M Mandal, Mikita Mankevich, Rajam S Mani, Shandy Shahabi, Manohar Kodavati, Sravan Gopalkrishnashetty Sreenivasmurthy, Nisha Tapryal, Dale J Hamilton, Balaji Krishnan, Muralidhar L Hegde, Michael Weinfeld und 2 weitere

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.111156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Anirban Chakraborty und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Huntington Disease, Genome, Mitochondrial. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Institute on Aging, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several reports have indicated that impaired mitochondrial function contributes to the development and progression of Huntington's disease (HD). Mitochondrial genome damage, particularly DNA strand breaks, is a potential cause for its compromised functionality. Here we show that the activity of polynucleotide kinase 3'-phosphatase (PNKP), a critical DNA end-processing enzyme, is significantly decreased in the mitochondrial extract of brains of patients with HD due to a lower level of fructose-2,6 bisphosphate (F2,6BP), a biosynthetic product of 6-phosphofructo-2-kinase fructose-2,6-bisphosphatase 3 (PFKFB3). Such decrease in PNKP activity leads to persistent DNA strand breaks that are refractory to subsequent steps for repair completion. Both PFKFB3 and F2,6BP, an allosteric modulator of glycolysis, are also present in the mitochondria, and PFKFB3 is part of a mitochondrial DNA repair complex containing HTT, PNKP, DNA Pol γ (POLG), and Lig IIIα. Notably, PNKP binds F2,6BP (Kd = 525 ± 25 nM) and utilizes it as a cofactor. The levels of both F2,6BP and PFKFB3 are significantly decreased in the mitochondrial extract of HD mouse striatal neuronal cells and patients' brain. Activity of PNKP is thus severely decreased in the mitochondrial extract; however, addition of F2,6BP restored its activity. Moreover, supplementation of F2,6BP in HD cells restored PFKFB3 level, mitochondrial genome integrity and partially restored mitochondrial membrane potential, mitochondrial respiration and prevented pathogenic aggregate formation. Importantly, F2,6BP supplementation significantly restored mitochondrial genome integrity in an HD Drosophila model. Our findings, therefore, suggest that F2,6BP-mediated restoration of PNKP activity could have a profound impact in ameliorating neurodegenerative symptoms in HD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseGenome, MitochondrialHumansAnimalsMicePhosphotransferases (Alcohol Group Acceptor)MitochondriaDNA Repair EnzymesDNA, MitochondrialMale

Stichwörter der Autor:innen

DNA strand break repairHuntington’s diseasePNKPfructose-2,6-bisphosphatemitochondria

Substanzen

Phosphotransferases (Alcohol Group Acceptor)DNA Repair EnzymesDNA, MitochondrialPNKP protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • Department of Chemistry and Biochemistry, University of California San Diego, LA Jolla, California, USA.
  • Department of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Department of Neurosurgery, Center for Neuroregeneration, The Houston Methodist Research Institute, Houston, Texas, USA.
  • Department of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Center for Bioenergetics, Charles W. Duncan Jr. Department of Medicine, The Houston Methodist Research Institute, Houston, Texas, USA.

Förderung

  • NINDS NIH HHS
  • National Institute on Aging
  • Alzheimer's Association
  • National Institutes of Health
  • University of Texas Medical Branch
  • University of Alberta

Zitieren

APA

Chakraborty, A., Mandal, S. M., Mankevich, M., Mani, R. S., Shahabi, S., Kodavati, M., Sreenivasmurthy, S. G., Tapryal, N., Hamilton, D. J., Krishnan, B., Hegde, M. L., Weinfeld, M., Ghosh, G., & Hazra, T. (2026). F2,6BP restores mitochondrial genome integrity in Huntington’s disease. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.111156

Vancouver

Chakraborty A, Mandal SM, Mankevich M, Mani RS, Shahabi S, Kodavati M, et al. F2,6BP restores mitochondrial genome integrity in Huntington’s disease. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.111156

BibTeX
@article{Chakraborty2026,
  author = {Chakraborty, Anirban and Mandal, Santi M and Mankevich, Mikita and Mani, Rajam S and Shahabi, Shandy and Kodavati, Manohar and Sreenivasmurthy, Sravan Gopalkrishnashetty and Tapryal, Nisha and Hamilton, Dale J and Krishnan, Balaji and Hegde, Muralidhar L and Weinfeld, Michael and Ghosh, Gourisankar and Hazra, Tapas},
  title = {F2,6BP restores mitochondrial genome integrity in Huntington’s disease},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.111156}
}
Kostenlos starten →